Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

NCT00005626

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00079261

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
Locations: U.Z. Gasthuisberg Leuven, Belgium

Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium

University Hospital Rebro Zagreb, Croatia

National Cancer Institute - Cairo Cairo, Egypt

View Trial Details

Completed

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00039351

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +10 more
Locations: Ziekenhuis Network Antwerpen Middelheim Antwerp, Belgium

Centre Hospitalier Universitaire Brugmann Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

National Cancer Institute of Egypt Cairo, Egypt

View all 17 locations

View Trial Details

Completed

PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma

NCT00054665

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

Roswell Parck Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne

NCT01682200

Conditions: Acne Vulgaris, Acneiform Eruptions, Hemic and Lymphatic Diseases, +12 more
Locations: Mary Chile General Hospital Manila, National Capital Region, Philippines

Far Eastern University Hospital, Dept of Family Medicine Quezon City, National Capital Region, Philippines

View Trial Details

Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Spedali Civili di Brescia Brescia, Italy

Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy

Ospedale San Carlo Potenza, Italy

Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy

View all 17 locations

View Trial Details

Completed

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

NCT01549145

Conditions: Ear Diseases, Hearing Disorders, Hemic and Lymphatic Diseases, +16 more
Locations: Shaare Zedek Medical Center Jerusalem, Israel

View Trial Details

Completed

Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma

NCT00748319

Conditions: Dermatitis, Dermatitis, Exfoliative, Disease, +18 more
Locations: Groupe hospitalier Henri Mondor - Albert Chenevier Créteil, France

View Trial Details

Completed

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

NCT00535470

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Stanford University Medical Center Stanford, California, United States

Northwestern University-Dept. of Dermatology Chicago, Illinois, United States

Columbia University, Dept of Dermatology New York, United States

NYU Medical Center Dept. of Dermatology New York, United States

View Trial Details

Completed

Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma

NCT01341119

Conditions: Extranodal NK/T Cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions